Enhancement of mucosal immunity and CTL avidity against HIV-1
Enhancement of mucosal immunity and CTL avidity against HIV-1
批准号:
nhmrc : 525431
负责人:
A/Pr Charani Ranasinghe
金额:
$36.88万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2009
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2009-01-01 至 2014-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Production of strong antiviral immunity at the local mucosa (genito-rectal track) is essential for protection against HIV-AIDS. We believe that expression of small hormone-like molecules known as Th2 cytokines IL-4-IL-13 negatively influence the generation of protective immunity against HIV. Thus we aim to counteract these effects by co-expressing proteins known as chemokines together with vaccine antigens to improve the quality of mucosal vaccine immunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mucosal human immunodeficiency virus vaccine late pre-clinical evaluation
-
批准号:nhmrc : 1136351
-
项目类别:Development Grants
-
资助金额:$38.9万
-
财政年份:2018
-
负责人:A/Pr Charani Ranasinghe
-
依托单位:
Mucosal human immunodeficiency virus vaccine late pre-clinical evaluation
-
批准号:nhmrc : GNT1136351
-
项目类别:Development Grants
-
资助金额:$57.53万
-
财政年份:2018
-
负责人:A/Pr Charani Ranasinghe
-
依托单位:
Pre-clinica evaluation of a novel HIV-1 vaccine statrgy
-
批准号:nhmrc : 1093532
-
项目类别:Development Grants
-
资助金额:$35.24万
-
财政年份:2015
-
负责人:A/Pr Charani Ranasinghe
-
依托单位:
A novel strategy to enhance T cell-mediated immunity to vaccine antigens
-
批准号:nhmrc : 1000703
-
项目类别:Development Grants
-
资助金额:$15.64万
-
财政年份:2010
-
负责人:A/Pr Charani Ranasinghe
-
依托单位:
国内基金
海外基金
新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
-
批准号:82371711
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:吕志宝
-
依托单位:
紧密连接蛋白PARD3下调介导黏膜上皮屏障破坏激活STAT3/SNAI2通路促进口腔白斑病形成及进展的机制研究
-
批准号:82370954
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:沈雪敏
-
依托单位:
奶牛乳腺黏膜抗感染免疫机制研究
-
批准号:30972225
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:张乃生
-
依托单位: